Literature DB >> 15980593

In vitro preparation of prefibrillar intermediates of amyloid-beta and alpha-synuclein.

Hilal A Lashuel1, Dolors Grillo-Bosch.   

Abstract

Elucidating the structural properties of early intermediates (protofibrils) on the fibril formation pathway of Abeta and alpha-synuclein, the structural relationship among the different intermediates and their relationship to the structure of the amyloid fibrils is critical for understanding the roles of amyloid fibril formation in the pathogenesis of Alzheimer's and Parkinson's diseases. In this chapter we discuss several methods, developed by different laboratories, that enable the preparation and stabilization of amyloid-beta and alpha-synuclein protofibrillar species of defined morphologies for biochemical, biophysical and toxicity studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15980593     DOI: 10.1385/1-59259-874-9:019

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  10 in total

Review 1.  Drug targets from genetics: α-synuclein.

Authors:  Karin M Danzer; Pamela J McLean
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-09-01       Impact factor: 4.388

2.  Aβ40 has a subtle effect on Aβ42 protofibril formation, but to a lesser degree than Aβ42 concentration, in Aβ42/Aβ40 mixtures.

Authors:  Shana E Terrill-Usery; Benjamin A Colvin; Richard E Davenport; Michael R Nichols
Journal:  Arch Biochem Biophys       Date:  2016-03-21       Impact factor: 4.013

3.  The Aggregation Paths and Products of Aβ42 Dimers Are Distinct from Those of the Aβ42 Monomer.

Authors:  Tiernan T O'Malley; William M Witbold; Sara Linse; Dominic M Walsh
Journal:  Biochemistry       Date:  2016-10-26       Impact factor: 3.162

4.  Detecting morphologically distinct oligomeric forms of alpha-synuclein.

Authors:  Sharareh Emadi; Srinath Kasturirangan; Min S Wang; Philip Schulz; Michael R Sierks
Journal:  J Biol Chem       Date:  2009-01-13       Impact factor: 5.157

Review 5.  Inflammatory mechanisms in neurodegeneration.

Authors:  Michael R Nichols; Marie-Kim St-Pierre; Ann-Christin Wendeln; Nyasha J Makoni; Lisa K Gouwens; Evan C Garrad; Mona Sohrabi; Jonas J Neher; Marie-Eve Tremblay; Colin K Combs
Journal:  J Neurochem       Date:  2019-03-27       Impact factor: 5.372

6.  Amyloid-beta(1-42) fibrillar precursors are optimal for inducing tumor necrosis factor-alpha production in the THP-1 human monocytic cell line.

Authors:  Deepa Ajit; Maria L D Udan; Geeta Paranjape; Michael R Nichols
Journal:  Biochemistry       Date:  2009-09-29       Impact factor: 3.162

Review 7.  The slowly aggregating salmon Calcitonin: a useful tool for the study of the amyloid oligomers structure and activity.

Authors:  Marco Diociaiuti; Maria Cristina Gaudiano; Fiorella Malchiodi-Albedi
Journal:  Int J Mol Sci       Date:  2011-12-13       Impact factor: 5.923

Review 8.  Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease.

Authors:  Shengli Xu; Piu Chan
Journal:  Biomolecules       Date:  2015-06-05

Review 9.  Molecular pathology of Lewy body diseases.

Authors:  Katrin Beyer; Montserrat Domingo-Sàbat; Aurelio Ariza
Journal:  Int J Mol Sci       Date:  2009-02-26       Impact factor: 5.923

10.  Structural characteristics and membrane interactions of tandem α-synuclein oligomers.

Authors:  Chunhua Dong; Marion Hoffmann; Xi Li; Meijing Wang; Craig R Garen; Nils O Petersen; Michael T Woodside
Journal:  Sci Rep       Date:  2018-04-30       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.